Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients

NCT05914857 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yangjin

Collaborators